Effects of the addition of second-messenger effectors to platelet concentrates separated from whole-blood donations and stored at 4 degrees C or -80 degrees C
M. Lozano et al., Effects of the addition of second-messenger effectors to platelet concentrates separated from whole-blood donations and stored at 4 degrees C or -80 degrees C, TRANSFUSION, 40(5), 2000, pp. 527-534
BACKGROUND: Platelet concentrates (PCs) are currently stored at 22 degrees
C under continuous agitation. Because of the potential risk of the overgrow
th of bacteria in case of contamination, PC shelf life is limited to 5 days
. A mixture of second-messenger effecters is being evaluated to determine i
f it has benefits for cold liquid storage and cryopreservation of platelets
.
STUDY DESIGN AND METHODS: PCs separated from whole-blood donations by the b
uffy coat method were randomly assigned (n = 6 each) to be stored for 5 day
s at 22 degrees C under continuous agitation or at 4 degrees C after treatm
ent with a platelet storage medium (ThromboSol, LifeCell Corp.). PCs were a
lso cryopreserved with 6-percent DMSO (final concentration) or with Thrombo
Sol plus 2-percent DMSO (final concentration) (TC). After storage, platelet
s were analyzed by flow cytometry, transmission electron microscopy, and ag
gregation and perfusion techniques.
RESULTS: Cold liquid storage of ThromboSol-treated platelets resulted in a
lower binding of coagulation factor Va on the platelet surface than on plat
elets stored at 22 degrees C. In transmission electron microscopy, a conver
sion to spherical morphology was seen in the case of cold liquid storage. N
o difference between ThromboSol-treated platelets stored at 4 degrees C and
platelets stored at 22 degrees C was seen in perfusion studies. Cryopreser
vation in the presence of TC prevented the reduction in glycoprotein Ib and
IV expression on platelet surface that is seen in 2-percent DMSO-cryoprese
rved platelets. Platelets cryopreserved in TC covered, by thrombus, a signi
ficantly greater percentage of the perfused surface after the freezing and
thawing process.
CONCLUSION:ThromboSol-treated PCs separated from whole-blood donations by t
he buffy coat method, stored at 4"C for 5 days, or cryopreserved in the pre
sence of TC, maintained in vitro functional activity comparable to that ach
ieved by current methods of storage, although discoid morphology was not pr
eserved during cold liquid storage with ThromboSol.